BNP Paribas Financial Markets Has $720,000 Stock Position in Evolent Health, Inc. (NYSE:EVH)

BNP Paribas Financial Markets lifted its stake in Evolent Health, Inc. (NYSE:EVH) by 150.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,469 shares of the technology company’s stock after buying an additional 15,299 shares during the period. BNP Paribas Financial Markets’ holdings in Evolent Health were worth $720,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. William Blair Investment Management LLC raised its position in shares of Evolent Health by 35.2% during the second quarter. William Blair Investment Management LLC now owns 5,026,043 shares of the technology company’s stock worth $96,098,000 after purchasing an additional 1,308,376 shares during the period. First Light Asset Management LLC boosted its stake in shares of Evolent Health by 401.5% during the 2nd quarter. First Light Asset Management LLC now owns 1,445,305 shares of the technology company’s stock worth $27,634,000 after acquiring an additional 1,157,124 shares during the period. Engaged Capital LLC increased its holdings in shares of Evolent Health by 26.1% in the second quarter. Engaged Capital LLC now owns 4,111,458 shares of the technology company’s stock valued at $78,611,000 after purchasing an additional 850,000 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Evolent Health by 24.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,048,341 shares of the technology company’s stock valued at $39,164,000 after acquiring an additional 406,837 shares during the period. Finally, Foundry Partners LLC bought a new position in Evolent Health during the 3rd quarter worth $10,042,000.

Evolent Health Stock Performance

Shares of NYSE EVH opened at $11.40 on Friday. The firm has a 50 day moving average of $18.48 and a 200 day moving average of $22.61. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.58. Evolent Health, Inc. has a 12-month low of $10.82 and a 12-month high of $35.00. The firm has a market capitalization of $1.33 billion, a price-to-earnings ratio of -12.53 and a beta of 1.45.

Analysts Set New Price Targets

EVH has been the topic of a number of research analyst reports. Truist Financial restated a “buy” rating and issued a $33.00 price target on shares of Evolent Health in a research note on Tuesday, August 27th. Citigroup lowered their target price on Evolent Health from $33.00 to $21.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Oppenheimer lowered their target price on Evolent Health from $34.00 to $28.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. Barclays decreased their price objective on Evolent Health from $39.00 to $19.00 and set an “overweight” rating for the company in a report on Monday, November 11th. Finally, BTIG Research lowered their target price on shares of Evolent Health from $36.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $26.18.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.